Bullish indicating open at $55-$60, IPO prices at $37
Investing.com -- U.S. stock futures rose Thursday, as investors digested more corporate earnings, in particular from Big Tech giants.
Here are some of the biggest premarket U.S. stock movers today:
-
Meta Platforms (NASDAQ:META) stock climbed 6.2% after the Facebook and Instagram parent reported better-than-expected first-quarter results and upbeat guidance that pointed to increased spending on artificial intelligence, cooling fears about slowing AI demand.
-
Microsoft (NASDAQ:MSFT) stock rose 8.8% after the software giant reported better-than-expected fiscal third-quarter results, and issued surprisingly strong guidance, as its key cloud business continued to ride AI-fueled demand.
-
Apple (NASDAQ:AAPL) stock fell 1.5% after a U.S. federal judge ruled that the iPhone maker violated a 2021 court injunction intended to spur competition within its App Store, potentially exposing the tech giant to criminal contempt proceedings.
-
Tesla (NASDAQ:TSLA) stock rose 0.6% after chair Robyn Denholm denied a WSJ story that the board was looking for a change at CEO, adding that the board is “highly confident” in Elon Musk’s ability to “continue executing on the exciting growth plan ahead.”
-
McDonald’s (NYSE:MCD) stock fell 1.1% after the fast food giant posted a surprise decline in first-quarter global comparable sales, with CEO Chris Kempczinski adding the company was navigating the "toughest of market conditions."
-
Eli Lilly (NYSE:LLY) stock dropped 4.1% after the drugmaker posted better-than-expected first quarter revenue and profit, although sales of its popular weight-loss drug, Zepbound, came in below expectations.
-
Biogen (NASDAQ:BIIB) stock rose 0.8% after the drugmaker beat first-quarter profit and revenue expectations, as strong demand for its rare disease drugs helped offset declining sales of its multiple sclerosis drugs.
-
General Motors (NYSE:GM) stock rose 2.8% despite the auto giant lowering its full-year guidance to reflect an estimated impact of $4 billion to $5 billion due to tariffs.
-
CVS Health (NYSE:CVS) stock rose 6.4% after the healthcare giant reported first-quarter earnings that surpassed analyst estimates and raised its full-year guidance.
-
Moderna (NASDAQ:MRNA) stock fell 1.9% after the U.S. drugmaker reported a first-quarter loss, while its revenue plunged 35% year-over-year, missing expectations.
-
Estee Lauder (NYSE:EL) stock rose 0.4% after the cosmetics giant reported better-than-expected third quarter results, even as it cited ongoing challenges in its travel retail business and subdued consumer sentiment in Asia.